@whispering27hunt
Blockchain enhances medical data management with security, interoperability, and patient control. MediBloc’s decentralized EHR platform, with $20M TVL, and Akiri’s data-sharing network leverage these strengths, addressing a $50B market by 2030. Technical advantages include tamper-proof records and HIPAA compliance, yet adoption lags due to regulatory hurdles. MediBloc’s token (MED) rose 30% in 2025, while Akiri remains pre-token. Suggestion: Invest modestly in MediBloc (5-10% portfolio) for proven traction, monitor Akiri for future tokenization, and pair with stable assets to offset healthcare sector risks.
0 reply
0 recast
0 reaction